Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia is a research paper published in Cancer Discovery (2021). On theSindex it has a DataRank of 0. It has been cited 42 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R01 DK68634
Carbone Cancer Center
Grant: P30 CA014520
NIH
Grant: T32 HL07899
Austrian Science Fund
Grant: F4710
Boehringer Ingelheim
Grant: FFG-852936
NIDDK NIH HHS
Grant: R01 DK068634
NHLBI NIH HHS
Grant: T32 HL007899
European Hematology Association
Grant: TRTH147
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: R01 CA204396
National Institutes of Health
Grant: 5P30CA014520-18
CANCER CENTER SUPPORT
National Institutes of Health
Grant: 5R01DK068634-13
Hematopoietic Regulation via GATA Switches
National Institutes of Health
Grant: 5T32HL007899-22
Research Training in Hematology
Fields of Study
MeSH Terms
Keywords